Position in ENTA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$895,263
-$1,749,586 QoQ
Shares Held
70,884
-57.7% QoQ
Ownership
0.244%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ENTA Over Time
Shares Held
Position Value (USD)
Derivatives in ENTA
reported options exposure · as of Mar 31, 2020CallValue
$0
CallShares
0
PutValue
$514,300
PutShares
10,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026D. E. Shaw & Co., Inc. holds $4,382,181,502 across 180 Biotechnology names. ENTA ranks #145 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
5,625,825 | $919,934,903 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,059,062 | $350,411,843 | |
| 3 | BBIO |
BridgeBio Pharma, Inc.
|
2,545,486 | $189,027,789 | |
| 4 | PCVX |
Vaxcyte, Inc.
|
2,865,318 | $166,503,628 | |
| 5 | EXEL |
Exelixis, Inc.
|
3,603,063 | $154,535,371 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
1,868,708 | $120,774,597 | |
| 7 | PTCT |
Ptc Therapeutics, Inc.
|
1,640,381 | $111,759,157 | |
| 8 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
248,960 | $111,170,598 |
All Filings in ENTA
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $895,263 | 70,884 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $2,644,849 | 167,714 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $2,702,155 | 225,744 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $2,134,006 | 282,276 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $2,115,926 | 383,320 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $2,424,165 | 421,594 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $5,194,213 | 501,372 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $6,928,326 | 534,181 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $9,956,494 | 570,246 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $6,005,160 | 638,168 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $4,032,950 | 361,052 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $1,124,548 | 52,549 | Shares | Defined | 2023-08-14 | |
| 2022-12-31 | $220,551 | 4,741 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $245,915 | 4,741 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $224,107 | 4,741 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $434,553 | 6,105 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $1,832,708 | 24,508 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $587,188 | 10,336 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $1,088,807 | 24,740 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $2,031,194 | 41,184 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $934,998 | 22,209 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $1,113,644 | 24,326 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $743,810 | 14,814 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $514,300 | 10,000 | Put | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||